2024. Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s344. DOI:https://doi.org/10.25251/skin.8.supp.344.